A solver of “mysteries” — Howard Nash, M.D., Ph.D.

A solver of “mysteries” — Howard Nash, M.D., Ph.D.

Global commonalities represent an opportunity for us to learn from the experiences in other countries or among other cultures to help improve mental health care in the U.S.

Mental health experts are calling for a greater world focus on improving access to care and treatment for mental, neurological, and substance use (MNS) disorders, as well as increasing discoveries in research that will enable this goal to be met.

The prevalence of autism spectrum disorder (ASD) among children in South Korea appears to be much higher than the range of estimates reported for other countries, according to a study partly funded by NIMH. Furthermore, two-thirds of ASD cases were found in children attending mainstream schools, had not been previously diagnosed, and had never received treatment for the disorder. The study was published on May 9, 2011, in the American Journal of Psychiatry.

Dr. Insel on investing in research.

An emerging research technology using Induced pluripotent stem cells holds promise as a window into the developing brain in mental illness.

The largest and most rigorous twin study of its kind to date has found that shared environment influences susceptibility to autism more than previously thought.

New studies published this Spring provide new insights into the molecular basis of autism, involving the interplay of genetic risk and environmental exposure.

A study in mice has pinpointed a pivotal new player in triggering the rapid antidepressant response produced by ketamine. By deactivating a little-known enzyme, the drug takes the brakes off rapid synthesis of a key growth factor thought to lift depression, say researchers supported by the National Institutes of Health.